Syndax Pharmaceuticals Inc
SNDX·Stocks·Biotechnology·United States·Nasdaq·USD
Price
$17.97
Today
+1.9%
YTD
-15.9%
About
Syndax Pharmaceuticals is a clinical-stage biopharmaceutical company that operates internationally. It works to develop therapies to treat cancer. Founded in 2005, the company has headquarters in Waltham, Massachusetts. Syndax Pharmaceuticals is listed on the NASDAQ GS stock market under the tickerSNDX. Follow SNDX share price movements with the help of your eToro watchlist.
Price chart
Closing price history for SNDX (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-8.45
P/S (TTM)9.58
P/B (TTM)50.23
Market cap$2.09B
Cap tierMid-cap
Industry avg P/E-6.22
Profitability
Gross margin95.99%
EBIT margin-102.81%
Net margin-65.79%
ROE-189.53%
ROA-43.70%
Earnings & Revenue
Revenue (TTM)$217.42M
Revenue growth (1Y)+397.3%
EPS (TTM)-$2.80
Free cash flow$-278.35M
Total debt$345.36M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.14
Employees298
Next earnings2 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.